Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia

被引：0
|
作者：
Mei-si Lin
Hui-Yun Zhong
Rita Lok-Hay Yim
Qi-Yan Chen
Hong-ling Du
Hao-qi He
Ke Lin
Peng Zhao
Ru Gao
Fei Gao
Min-Yue Zhang
机构：
[1] Chengdu University of Traditional Chinese Medicine,State Key Laboratory of Southwestern Chinese Medicine Resources, Pharmacy School
[2] Sichuan Vocational College of Health and Rehabilitation,Department of Medicine, Queen Mary Hospital
[3] The University of Hong Kong,School of Medical Information Engineering
[4] Chengdu University of Traditional Chinese Medicine,Department of Nursing
[5] Chengdu Wenjiang People’s Hospital,Division of Hematology, Renji Hospital, School of Medicine
[6] Shanghai Jiaotong University,undefined
来源：
BMC Cancer | / 22卷
关键词：
Acute myeloid leukemia; Prognosis; Immunomodulation; Oncogenic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia
    Lin, Mei-Si
    Zhong, Hui-Yun
    Yim, Rita Lok-Hay
    Chen, Qi-Yan
    Du, Hong-Ling
    He, Hao-Qi
    Lin, Ke
    Zhao, Peng
    Gao, Ru
    Gao, Fei
    Zhang, Min-Yue
    BMC CANCER, 2022, 22 (01)
  • [2] Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia
    Li, Fangmei
    Miao, Jiyu
    Liu, Rui
    Zhang, Ru
    He, Aili
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (03)
  • [3] Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia
    Fangmei Li
    Jiyu Miao
    Rui Liu
    Ru Zhang
    Aili He
    Journal of Cancer Research and Clinical Oncology, 150
  • [4] Immunological role and prognostic value of the SKA family in pan-cancer analysis
    Li, Zhengtian
    Huang, Lanying
    Li, Jiachen
    Yang, Wenkang
    Li, Weichao
    Long, Qiuzhong
    Dai, Xinyu
    Wang, Hongtao
    Du, Gang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
    Xie, Pan
    Liu, Jun-Yan
    Yan, Han
    Wang, Zhi-Bin
    Jiang, Shi-Long
    Li, Xi
    Liu, Zhao-Qian
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
    He, Kangwei
    Li, Changjiu
    Yuan, Hui
    Jiang, Kang
    Deng, Gang
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
  • [7] Comprehensive pan-cancer analysis reveals the prognostic value and immunological role of SPIB
    Ding, Meng
    Li, Qiufang
    Tan, Xiao
    Zhang, Liangyua
    Tan, Jun
    Zheng, Lan
    AGING-US, 2022, 14 (15): : 6338 - 6357
  • [8] Prognostic value and immunological role of PTPN21 in pan-cancer analysis
    Yang, Yane
    Yang, Wenchao
    Su, Xingxing
    Cheng, Caixia
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 48 (02) : 111 - 125
  • [9] Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer
    Huang, Da
    Shen, Jiayu
    Zhai, Lingyun
    Chen, Huanhuan
    Fei, Jing
    Zhu, Xiaoqing
    Zhou, Jianwei
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [10] Oncogenic and immunological values of RBM34 in osteosarcoma and its pan-cancer analysis
    Zhang, Wenchao
    He, Rong
    Cao, Wenbing
    Li, Dapeng
    Zheng, Qiping
    Zhang, Yiming
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (11): : 5094 - +
12345